Bridgebio Oncology Therapeutics Inc (BBOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||
| Net Income | -134,044 | -74,275 | N/A |
| Depreciation Amortization | 610 | 208 | N/A |
| Accounts payable and accrued liabilities | -1,840 | 2,498 | N/A |
| Other Working Capital | 6,433 | 15,594 | N/A |
| Other Operating Activity | 14,947 | 948 | 0 |
| Operating Cash Flow | $-113,894 | $-55,027 | $N/A |
| Cash Flows From Investing Activities | |||
| Change In Deposits | 73,934 | -122,887 | N/A |
| PPE Investments | -606 | -49 | N/A |
| Other Investing Activity | 0 | 2,406 | 0 |
| Investing Cash Flow | $73,328 | $-120,530 | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 45 | 52 | N/A |
| Other Financing Activity | 383,357 | 206,238 | 0 |
| Financing Cash Flow | $383,402 | $206,290 | $N/A |
| Beginning Cash Position | 30,983 | 250 | N/A |
| End Cash Position | 373,819 | 30,983 | N/A |
| Net Cash Flow | $342,836 | $30,733 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -113,894 | -55,027 | N/A |
| Capital Expenditure | -606 | -49 | N/A |
| Free Cash Flow | -114,500 | -55,076 | 0 |